Showing results (3061-3070 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|September 1, 1988
Hemin acts synergistically with interleukin-3 to promote the growth of multipotent stem cells (CFU-GEMM) in "serum-free" cultures of normal murine bone marrowF C Monette, G SigounasExperimental Hematology|June 29, 2020
The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2Laura C Siegwart, Sven Schwemmers, Julius Wehrle, et al.Experimental Hematology|November 1, 1988
Purification and assay of a phosphatidylglycerol-stimulated protein kinase from murine leukemic cells and its perturbation in response to IL-3 and PMA treatmentD J Klemm, L EliasExperimental Hematology|October 23, 2012
Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasiaTeresa Bernal, Angela Moncada-Pazos, Clara Soria-Valles, et al.Experimental Hematology|March 1, 1976
Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxinW C Rose, G E Rodey, A A Rimm, et al.Experimental Hematology|March 23, 2010
Regeneration capability of Lin-/c-Kit+/Sca-1+ cells with or without radiation exposure for repopulation of peripheral blood in lethally irradiated mice monitored using Ly5.1 isotype on days 35, 90, and 270 after transplantationKensuke Otsuka, Yoko Hirabayashi, Isao Tsuboi, et al.Experimental Hematology|January 1, 1979
Terminal deoxynucleotidyl transferase as a leukemic marker in bone marrow transplant recipientsK G Blume, E Beutler, W KuhlExperimental Hematology|June 3, 2014
Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3Thomas Nerreter, Christoph Köchel, Daniel Jesper, et al.Experimental Hematology|June 28, 2014
Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximabLudmila Sebejova, Marek Borsky, Zuzana Jaskova, et al.Experimental Hematology|November 1, 2012
Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2(V617F) myeloproliferative neoplasm patientsAriel Amaru Calzada, Olga Pedrini, Guido Finazzi, et al.Pageof 652